» Articles » PMID: 8490669

The Scientific Basis of Calcium Oxalate Urolithiasis. Predilection and Precipitation, Promotion and Proscription

Overview
Journal World J Urol
Specialty Urology
Date 1993 Jan 1
PMID 8490669
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The documentation of no other human disease threads as far into antiquity as that of urinary stones. However, despite this arcane history and the development of novel means of treating the condition, the basic mechanisms of stone formation and the identity of indicators of recurrence remain largely shrouded in uncertainty. This review is concerned with what scientific information is known about the cause and formation of calcium oxalate stones--the most common component of human uroliths. Stone pathogenesis can be broadly divided into two main processes: (1) nucleation of insoluble crystals in urine and (2) retention of those crystals within the urinary tract. The first section of the article presents the various factors that are known or surmised to influence the likelihood that crystals will nucleate within the renal collecting system, and these are considered from the perspective of both their relation to metabolic disorders and their usefulness as diagnostic and therapeutic indicators. A discussion of factors that may influence the probability that newly formed crystals will be retained within the nephron forms the second part of the review. In developing this more mechanistic aspect of the disease the epitaxy, matrix and inhibitor theories of stone formation are presented, with particular emphasis being placed on their relation to crystal nucleation, growth or aggregation, and experimental evidence both for and against the hypotheses are discussed.

Citing Articles

Peeping into human renal calcium oxalate stone matrix: characterization of novel proteins involved in the intricate mechanism of urolithiasis.

Aggarwal K, Tandon S, Naik P, Singh S, Tandon C PLoS One. 2013; 8(7):e69916.

PMID: 23894559 PMC: 3722206. DOI: 10.1371/journal.pone.0069916.


Label-free quantitative proteomics reveals differentially regulated proteins influencing urolithiasis.

Wright C, Howles S, Trudgian D, Kessler B, Reynard J, Noble J Mol Cell Proteomics. 2011; 10(8):M110.005686.

PMID: 21474797 PMC: 3149087. DOI: 10.1074/mcp.M110.005686.


Protein content of human apatite and brushite kidney stones: significant correlation with morphologic measures.

Pramanik R, Asplin J, Jackson M, Williams Jr J Urol Res. 2008; 36(5):251-8.

PMID: 18779958 PMC: 2912700. DOI: 10.1007/s00240-008-0151-7.


Morphological analysis of renal cell culture models of calcium phosphate stone formation.

Naito Y, Ohtawara Y, Kageyama S, Nakano M, ICHIYAMA A, Fujita M Urol Res. 1997; 25(1):59-65.

PMID: 9079747 DOI: 10.1007/BF00941907.


Hyperoxaluria and renal calculi.

Woolfson R, Mansell M Postgrad Med J. 1994; 70(828):695-8.

PMID: 7831162 PMC: 2397769. DOI: 10.1136/pgmj.70.828.695.

References
1.
CRASSWELLER P, Oreopoulos D, Toguri A, HUSDAN H, Wilson D, Rapoport A . Studies in inhibitors of calcification and levels of urine saturation with calcium salts in recurrent stone patients. J Urol. 1978; 120(1):6-10. DOI: 10.1016/s0022-5347(17)57021-4. View

2.
Hodgkinson A . Uric acid disorders in patients with calcium stones. Br J Urol. 1976; 48(1):1-5. DOI: 10.1111/j.1464-410x.1976.tb02729.x. View

3.
MELICK R, Quelch K, Rhodes M . The demonstration of sialic acid in kidney stone matrix. Clin Sci (Lond). 1980; 59(5):401-4. DOI: 10.1042/cs0590401. View

4.
Resnick M, Sorrell M, Bailey J, Boyce W . Inhibitory effects of urinary calcium-binding substances on calcium oxalate crystallization. J Urol. 1982; 127(3):568-71. DOI: 10.1016/s0022-5347(17)53913-0. View

5.
KALLISTRATOS G, Timmermann A, FENNER O . [Influence of the salting-out effect on the formation of calcium oxalate crystals in human urine]. Naturwissenschaften. 1970; 57(4):198. DOI: 10.1007/BF00592988. View